| Identification | Back Directory | [Name]
IN 1130 | [CAS]
868612-83-3 | [Synonyms]
IN 1130
IN1130,IN 1130
3-[[5-(6-Methyl-2-pyridinyl)-4-(6-quinoxalinyl)-1H-imidazol-2-yl]methyl]benzamide | [Molecular Formula]
C25H20N6O | [MDL Number]
MFCD19441274 | [MOL File]
868612-83-3.mol | [Molecular Weight]
420.47 |
| Chemical Properties | Back Directory | [Boiling point ]
705.6±60.0 °C(Predicted) | [density ]
1.315±0.06 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
Soluble in DMSO | [form ]
Solid | [pka]
9.60±0.10(Predicted) | [color ]
White to light yellow |
| Hazard Information | Back Directory | [Uses]
IN 1130 is a novel transforming growth factor-?β type I receptor kinase (ALK5) inhibtior. In one study, it showed that IN-1130 was effective in prevention and treatment of renal fibrosis in rat unilateral ureteral obstruction model. | [storage]
Store at -20°C |
|
| Company Name: |
cjbscvictory
|
| Tel: |
13348960310 13348960310 |
| Website: |
https://www.weikeqi-biotech.com/ |
| Company Name: |
|
| Tel: |
|
| Website: |
www.sangon.com |
|